Latash Investments’s Acadia Healthcare ACHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-4,482
Closed -$284K 17
2024
Q3
$284K Hold
4,482
0.26% 17
2024
Q2
$303K Hold
4,482
0.25% 17
2024
Q1
$355K Hold
4,482
0.25% 18
2023
Q4
$349K Hold
4,482
0.25% 17
2023
Q3
$315K Hold
4,482
0.27% 17
2023
Q2
$357K Hold
4,482
0.29% 18
2023
Q1
$324K Hold
4,482
0.29% 18
2022
Q4
$369K Hold
4,482
0.3% 17
2022
Q3
$350K Hold
4,482
0.28% 19
2022
Q2
$303K Hold
4,482
0.25% 20
2022
Q1
$294K Hold
4,482
0.19% 22
2021
Q4
$272K Hold
4,482
0.17% 21
2021
Q3
$286K Hold
4,482
0.18% 21
2021
Q2
$281K Buy
+4,482
New +$281K 0.18% 20

Other funds holding ACHC

Latash Investments's ACHC Position: Q4 2024 in Review

Latash Investments sold out of Acadia Healthcare (ACHC) in Q4 2024, closing a stake of 4,482 shares — an estimated $284K sold.

Latash Investments first reported a position in ACHC in Q2 2021 and held it in 14 quarters. The position peaked at $369K in Q4 2022. 306 funds tracked by Wall St. Rank hold ACHC as of Q4 2024.

  • Latash Investments reported no remaining Acadia Healthcare position as of Q4 2024 after selling out during the quarter.
  • Latash Investments sold 4,482 Acadia Healthcare shares in Q4 2024, an estimated $284K.
  • Latash Investments first reported a position in Acadia Healthcare in Q2 2021 and held it in 14 quarters.
  • Latash Investments's Acadia Healthcare position peaked at $369K in Q4 2022.
  • 306 funds tracked by Wall St. Rank held Acadia Healthcare as of Q4 2024.

Based on Latash Investments's 13F filing for Q4 2024, filed 12 Feb 2025.